Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pRK5-HA-PRAS40 Citations (2)

Originally described in: Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH Nat Cell Biol. 2007 Mar . 9(3):316-23.
PubMed Journal

Articles Citing pRK5-HA-PRAS40

Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity. Chan TO, Zhang J, Rodeck U, Pascal JM, Armen RS, Spring M, Dumitru CD, Myers V, Li X, Cheung JY, Feldman AM. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):E1120-7. doi: 10.1073/pnas.1109879108. Epub 2011 Oct 26. PubMed
PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. Yang W, Yang LF, Song ZQ, Shah SZA, Cui YY, Li CS, Zhao HF, Gao HL, Zhou XM, Zhao DM. CNS Neurosci Ther. 2017 May;23(5):416-427. doi: 10.1111/cns.12685. Epub 2017 Mar 14. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.